Aisling Capital Management LP

Company Share, %
Elevation Oncology, Inc. Elevation Oncology, Inc. 5.19
BridgeBio Pharma, Inc. BridgeBio Pharma, Inc. 3.16
Biomea Fusion, Inc. Biomea Fusion, Inc. 2.9
Eidos Therapeutics, Inc. Eidos Therapeutics, Inc. 2.89
Reneo Pharmaceuticals, Inc. 2.65
Marker Therapeutics, Inc. Marker Therapeutics, Inc. 2.51
AVROBIO, Inc. AVROBIO, Inc. 2.25
Atreca, Inc. 1.18
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc. 1.08

Category Quantity
Healthcare 9